Bill > HB61

This bill creates new legal restrictions for Delaware-based organizations regarding the sale of drugs that could be used in government-sanctioned executions. Specifically, the bill prohibits any organization organized under Delaware law from selling, distributing, or dispensing drugs if its highest-ranking officer knows or should know the drugs will be used in an execution. The legislation requires drug sellers to obtain a signed attestation from purchasers confirming the drug will not be used for executions, particularly focusing on pentobarbital, a drug commonly used in lethal injection protocols. Violations of this law carry significant penalties, including potential criminal charges (a class A felony), civil fines up to $50,000, and for corporations, the possibility of having their corporate charter revoked. The bill defines "organization" broadly to include most business entities and places direct liability on corporate officers who are aware of or should be aware of such drug sales. This legislation appears aimed at making it more difficult for pharmaceutical companies and other organizations to participate in the execution process by creating substantial legal and financial disincentives.

Justice

https://legis.delaware.gov/BillDetail?LegislationId=141893